Abstract:Wenyu Bao, &ast Junkang Gao, &ast Siyu Fang, Shiwei Zhang, Yufeng Wan Department of Otolaryngology, Head and Neck Surgery, Chaohu Hospital Affiliated to Anhui Medical University, Hefei, 238000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yufeng Wan, Department of Otolaryngology, Head and Neck Surgery, Chaohu Hospital Affiliated to Anhui Medical University, Hefei, 238000, People's Republic of China, Email Objective: This study aims to explore the correlation between serum monocyte-to-lymphocyte ratio (MLR) and other inflammatory parameters with the occurrence of obstructive sleep apnea-hypopnea syndrome (OSAHS) in patients. Methods: This study included 310 patients who underwent polysomnography monitoring at our hospital between January 2021 and January 2023. Routine blood inflammatory parameters and polysomnography (PSG) results were also evaluated. The differences in inflammatory markers between the OSAHS and normal groups were compared, and OSAHS independent related factors were screened. Results: The MLR of OSAHS group was significantly higher than that of control group, and the difference was statistically significant. Multivariate logistic regression analysis suggested that MLR is an independent risk factor for OSAHS. Conclusion: High MLR was correlated with OSAHS. The diagnostic value of MLR was better than that of the other inflammatory parameters. Keywords: obstructive sleep apnea hypopnea syndrome, inflammation, monocyte to lymphocyte ratio, polysomnography Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a common sleep disorder characterized by partial or complete obstruction of the upper airway during sleep, leading to pauses or reductions in breathing. These respiratory symptoms cause oxygen deprivation and impaired carbon dioxide elimination, typically accompanied by snoring, disrupted sleep patterns, and daytime symptoms such as excessive sleepiness and impaired concentration. 1 Epidemiological studies have shown that the global prevalence of sleep-disordered breathing (AHI ≥ 5 events/) in the population aged 30–69 years ranges from 711 million to 961 million, 2 Among them, an estimated 272 million to 458 million people have moderate to severe sleep-disordered breathing (AHI≥15 events/h). 3 The prevalence of OSA increases with age, male gender, and higher body mass index. 4 OSAHS can lead to fragmented sleep and decreased oxygen saturation. 5 Studies have shown that fragmented sleep can result in excessive daytime sleepiness, reduced quality of life 6 , and an increased risk of accidents. 7 Additionally, it increases the risk of developing other diseases, 8 including cardiovascular diseases, 9 neurological diseases, 10,11 metabolic diseases, 12 cancer and reproductive disorders. 13,14 OSAHS is currently recognized as an inflammatory disease. There is evidence to suggest that chronic intermittent hypoxia (IH) associated with OSAHS, sleep deprivation, and fragmentation can elevate levels of various markers such as inflammation, oxidative stress, procoagulant, and thrombotic activity. 15 The gold standard for diagnosing OSAHS is a polysomnography (PSG) examination, 16 which requires specialized facilities and overnight monitoring. Some researchers propose the use of biological and hematological parameters as biomarkers for early diagnosis and monitoring of OSAHS, 17 however, these methods are often costly and require additional testing. In recent years, the use of composite inflammatory parameters such as neutrophil-to-lymphocyte ratio (NLR) as specific biochemical markers for OSAHS has garnered increasing attention from researchers. NLR, MLR, systemic immune-inflammation index (SII), system inflammation response index (SIRI), and Pan-Immune-Inflammation Value (PIV) are biomarkers of endogenous stress and various disease risks, 18–22 and these composite inflammatory parameters are easily accessible and convenient to calculate. Studies have shown that NLR is associated with the severity of OSAHS. 23 Some research has investigated the relevance of SII and SIRI in the development of OSAHS 24,25 . However, there is currently no reported research on the relationship between MLR, PIV, and the occurrence of OSAHS, nor comparative studies of the association between different inflammatory parameters and the development of OSAHS. A total of 414 patients who underwent polysomnography (PSG) and complete blood count at the Chao Lake Hospital, Anhui Medical University, from January 2021 to May 2023 were retrospectively analyzed. PSG and blood tests were pe -Abstract Truncated-

The association between circulating APRIL levels and severity of obstructive sleep apnea in Chinese adults

Plasma APRIL as a Potential Biomarker in the Diagnosis of Obstructive Sleep Apnea

Effects of obstructive sleep apnea on inflammatory markers in patients with acute coronary syndrome

Changes in Plasma Interleukin-18 and Monocyte Chemotaxis Protein-1 in Obstructive Sleep Apnea Syndrome and Their Significance

Relationship of redundant Th17 cells and IL-17A, but not IL-17 F, with the severity of obstructive sleep apnoea/hypopnoea syndrome (OSAHS)

A Community Study of the Risk for Obstructive Sleep Apnea and Respiratory Inflammation in an Adult Chinese Population.

Elevated Levels of Interleukin‐35 and Interleukin‐37 in Adult Patients with Obstructive Sleep Apnea

Obstructive Sleep Apnea Hypopnea Syndrome,nuclear Factor-Κb and Atherosclerosis

The Relationship Between Obstructive Sleep Apnea Hypopnea Syndrome and Inflammatory Markers and Quality of Life in Subjects With Acute Coronary Syndrome.

The impact of obstructive sleep apnea hypopnea syndrome on the changes of peripheral blood lymphocyte immunophenotype and C-reactive protein

Causal Relationships Between Circulating Inflammatory Proteins and Obstructive Sleep Apnea: A Bidirectional Mendelian Randomization Study

Correlation Analysis of Characteristics of Intestinal Microbiota and Cytokine Levels in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

Changes and significances of serum interleukin-8 and monocyte chemoattractant protein-1 levels in patients with obstructive sleep apnea syndrome

Differences and Risk Factors of Peripheral Blood Immune Cells in Patients with Obstructive Sleep Apnea

Serum Periostin and TNF-α Levels in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome.

Association of CLDN molecules with sleep apnea hypopnea syndrome: new biomarker candidates

Alterations of IGF-1, Complement C3 and Superoxide Dismutase in Patients with Moderate-to-severe Obstructive Sleep Apnea Hypopnea Syndrome.

[Association between inflammation and cognitive function and effects of continuous positive airway pressure treatment in obstructive sleep apnea hypopnea syndrome].

Relationship of Daytime Blood Pressure and Severity of Obstructive Sleep Apnea among Chinese： a Multi-Center Investigation in China

High Monocyte-to-Lymphocyte Ratio is Associated with Obstructive Sleep Apnea Hypopnea Syndrome

Quantification of Circulating Cell-Free DNA in the Serum of Patients with Obstructive Sleep Apnea–Hypopnea Syndrome